A method is provided for producing prey organisms such as Artermia and rotifers, for feeding aquacultural organisms in particular at the larval stage. The method comprises cultivating the prey organisms during at least part of their life cycle in an aqueous medium comprising at least one lipid component having a DHA content of at least 30 wt %. The enriched prey organisms preferably have a DHA con...

A vaccine for reducing disease progression, and/or protection of motor nerve degeneration, and/or protection from glutamate toxicity in motor neurone disease (MND), particularly amyotrophic lateral sclerosis (ALS), patients, comprising an active agent selected from the group consisting of Cop 1, a Cop 1-related peptide, a Cop 1-related polypeptide, and poly-Glu, Tyr. The active agent is preferably...

Use of erythropoetin (EPO) and/or its derivatives for stimulating, in endothelial precursor cells (EPC), any of physiological mobilization; proliferation; differentiation to endothelial cells and/or migration, in the direction of an angiogenic or vasculogenic stimulus. Independent claims are also included for the following: (1) use of EPO and/or its derivatives for stimulating formation of endothe...

An oral dosage form comprising azithromycin and an effective amount of an alkalizing agent. Preferably, said oral dosage form comprises an effective amount of an alkalizing agent and an azithromycin multiparticulate wherein said multiparticulate comprises azithromycin, a mixture of glyceryl monobehenate, glyceryl dibehenate and glyceryl tribehenate, and a poloxamer. Typically, the oral dosage form...

N,N-Diisopropyl-3-(2-acyloxy-5-hydroxymethyl)-3-phenylpropylammonium salts (I) are new. Diphenylpropylamine derivative salts of formula (I) are new. [Image] R : 1-6C alkyl, 3-10C cycloalkyl or optionally substituted phenyl; X->residue of an organic or inorganic acid. Independent claims are included for new diphenylpropylamine derivatives of formulae (II). [Image] Q1COOMe; and Q2H or benzyl; or Q1C...

The invention provides a method for the preparation of enantiomerically pure mirtazapine, said method comprising a step of ring closure of a compound of formula (II) wherein X is a leaving group, said step comprising treatment with an acid, whereby mirlazapine with enantiomeric excess is formed by the ring closure of the compound of formula (II) with enantiomeric excess by treatment with a suitabl...

This invention relates to inhibitors of p38, and methods for producing these inhibitors. The invention also provides pharmaceutical compositions comprising the inhibitors of the invention and methods of utilizing the inhibitors and pharmaceutical compositions in the treatment and prevention of various disorders mediated by p38.

The invention provides compounds represented by the general formula (I) wherein the substituents are defined in the application. The compounds are useful in the treatment of an affective disorder, including depression, anxiety disorders including general anxiety disorder and panic disorder and obsessive compulsive disorder.

The present invention provides enteric polymer coated tablet formulations for oral administration which comprise a phospholipase A2 enzyme Lipoprotein Associated Phospholipase A2 (Lp-PLA2) inhibitor, processes for preparing such formulations and their use in therapy, in particular the treatment of atherosclerosis.

The present invention relates to fast dispersing solid dosage forms that preferably dissolve in the oral cavity within sixty (60), more preferably within thirty (30), most preferably within ten (10) seconds. A novel feature of the solid dosage forms according to the invention reside in the fact that the composition is essentially free or absolutely free of mammalian gelatin. It has been discovered...

The present invention relates to A microcapsule composition allowing the delayed and controlled release of perindopril, or of a pharmaceutically acceptable salt thereof, for administration by the oral route.

The present invention relates (a) to new compounds represented by Formula I: wherein M represents a macrolide subunit (macrolide moiety) derived from macrolide possessing the property of accumulation in inflammatory cells, V represents an anti-inflammatory steroid or nonsteroid subunit, or an antineoplastic or antiviral subunit and L represents a linking group covalently linking M and V; (b) to th...

A sustained release formulation of lamotrigine or a pharmaceutically acceptable derivative thereof and methods of treatment and uses thereof.

Constitution: two USB ports 1, 2, one input for battery, one four-direction joystick having a pressure button at the centre, one internal electronic circuit and one liquid crystal screen for the selection of files and the following up of the work progress which work is completed when the indication of dotted lines reach the right end of the screen. The files to be transferred from one flash memory...

The present invention discloses a switching control circuit for a primary-side controlled power converter. A voltage-waveform detector produces a voltage-feedback signal and a discharge-time signal. A current-waveform detector generates a current-waveform signal by measuring a primary-side switching current. An integrator generates a current-feedback signal by integrating the current-waveform sign...

A method for managing a connection in a communication network comprising a bridge interfacing at least two device clusters. The connection is established between a first device and a second device respectively connected to different clusters. The method comprises the steps of, at the level of an application adapted to establish said connection: requesting reserving resources for the connection ove...

A method includes receiving at least one transport block and determining from the at least one transport block a first data unit, wherein a portion but not all of the first, data unit includes a second data unit; determining information corresponding to acknowledgement status of the first data unit; determining, based at least on the information, whether a request should be performed requesting re...

The invention relates to a projection screen for representing static or animated images with the aid of one or several monochromatic laser light sources. Said projection screen is provided with a coating that reflects in a spectrally selective manner and a structured lacquer layer made of a hardened lacquer or a structured film made from a holographic master as a layer reflecting in a spatially se...

The instrument has a box (2) with an electronic module (6) and housed in a casing body (4). The module has a printed circuit board (60) with a conductive path (65) that extends along a periphery of the circuit board. A mechanical contact zone of the board establishes an electric contact with the casing body that is connected to a ground plane.

A polyol composition for rigid polyurethane foams, which is used in combination with HFC-245fa as a blowing agent at a reduced vapor pressure of the blowing agent. The blowing agent ingredient comprises 1,1,1,3,3-pentafluoropropan (HFC-245fa). The composition comprises diethylene glycol monoethyl ether acetate and one or more polyol compounds including a polyol compound having a tertiary amino gro...